International searches for Vietnam climb 21%, while domestic travel interest up 14% as travelers explore closer to home

HO CHI MINH CITY, Vietnam, Feb. 2, 2026 /PRNewswire/ — With the new year in full swing, digital travel platform Agoda reveals search data insights looking back at the travel trends that shaped Vietnam in 2025. The company saw 21% growth in international accommodation searches into the country compared to 2024.

The Vietnam National Administration of Tourism recently released data showing with a record-breaking 21.2 million international visitors landing on the nation’s shores in 2025 – a 20.4% increase over the year prior.

“Growing international interest suggests Vietnam is consolidating its position as a leading regional destination, benefiting from improved connectivity, visa policies, and diversified travel experiences,” said Vu Ngoc Lam, Agoda Vietnam Country Director.

South Korea remained the largest source market for international visitors searching for accommodation in Vietnam, with search interest growing 15% year-on-year. Japan climbed to second place with an 18% increase, relegating the United States to third. Thai travel interest rose by 36%, while Philippines interest into Vietnam grew 86% over the previous year, displacing Taiwan in the top five.

The destination leaderboard is largely consistent with 2024, but with increasing interest for all destinations being the key takeaway from 2025.  

Danang led the way, with accommodation searches up 25% year-on-year, ahead of HCMC (+26%), Nha Trang (+2%), Hanoi (+23%) and Phu Quoc rounding out the top five, with travel interest up 49% compared with the previous year.

Interest in domestic travel also grew, with accommodation searches increasing 14% over 2024.  

“The rise in domestic travel interest last year highlights Vietnamese travelers’ continued appetite for local exploration and short breaks within the country,” Lam added. “According to survey results from Agoda’s 2026 Travel Outlook Report, this trend is projected to continue throughout this year, as nearly half of Vietnamese travelers responded they plan to travel more domestically than internationally in 2026.”

Da Nang led domestic search growth, increasing 29% year-on-year. Hanoi (+28%) and Ho Chi Minh City (+17%) also saw rises in travel interest among domestic destinations.

Travelers planning their 2026 getaways can explore Agoda’s extensive offerings, including over 6 million holiday properties, more than 130,000 flight routes, and over 300,000 activities. Running from 14 to 28 February, Agoda’s Mega Sale will offer up to 60% off on hotel bookings, with special flash sales of up to 70% on 17 February and exclusive deals on flights and activities. Agoda VIP members will receive early access to deals from 10 to 13 February. The latest deals are available on the Agoda app or at agoda.com/deals.

— ENDS —  

Alliance to Enhance Shonan Beauty Clinic Brand Recognition in China and Support Growth in Inbound Medical Demand to Japan

IRVINE, Calif., Feb. 2, 2026 /PRNewswire/ — SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Medical Corporation Nasukai, a Japan-based medical corporation supported by SBC Medical and the operator of Shonan Beauty Clinic, has entered into a strategic business alliance with Daibi Medical Aesthetics, a medical aesthetic clinic based in Shanghai, China. The alliance aims to enhance the quality of services at Daibi Medical Aesthetics by sharing Nasukai’s clinical expertise, operational know-how, and customer-centered practices cultivated by its long-standing experience in aesthetic medicine. The collaboration also seeks to strengthen recognition in China of the Shonan Beauty Clinic brand’s safety standards and advanced medical technologies.

These efforts aim to deepen SBC Medical’s understanding of China’s medical environment and customer needs, while supporting increased inbound customer visits to Shonan Beauty Clinic in Japan and exploring long-term revenue opportunities associated with growing cross-border medical demand.

Established in 2021, Daibi Medical Aesthetics subsequently opened its clinic in 2022 in Shanghai’s North Bund area. The clinic operates approximately 2,200 square meters of floor space and provides community-based medical aesthetic services. Under the alliance, physicians affiliated with Nasukai will work within Daibi Medical Aesthetics’ clinical framework to share knowledge and expertise related to medical safety, clinic operations, and consultation practices. The two parties will also explore opportunities to promote mutual understanding and professional exchange in the field of aesthetic medicine between Japan and China, with specific initiatives being considered in phases.

The alliance comes amid growing global interest in medical tourism, defined as international travel for the purpose of receiving medical services. According to Fortune Business Insights, the global medical tourism market is projected to grow at a compound annual growth rate (CAGR) of 23.0% from 2024 to 2032, reaching approximately USD 62.18 billion by 2032.

As global interest in medical tourism continues to rise, Japanese aesthetic medicine has gained strong recognition, particularly across Asia, for its advanced medical technologies, safety standards, and attentive consultation practices. Reflecting this trend, inbound customer visits to Shonan Beauty Clinic have increased steadily, nearly tripling from approximately 600 customers in early 2024 to around 1,700 customers by the end of 2025.To support this growing demand, Shonan Beauty Clinic has enhanced its inbound medical infrastructure through initiatives such as the development of Chinese-language translation tools and the renewal of its Chinese and English language official websites, providing overseas customers with clear and reliable medical information and a supportive care environment.

Shonan Beauty Clinic (Chinese): https://cn.sbc-beauty.com/
Shonan Beauty Clinic (English): https://en.sbc-beauty.com/

This alliance is expected to further support these efforts by enabling deeper insight into medical practices and customer expectations in China, contributing to a more seamless and consistent customer experience from pre-visit information to post-treatment follow-up, while also supporting improvements in the quality and reliability of aesthetic medical services at the local level.

Through its consulting and management support for medical institutions including Shonan Beauty Clinic, SBC Medical remains committed to building constructive partnerships with local stakeholders, fostering sustainable international medical exchange through medical tourism, and delivering customer-centered medical care that transcends national and regional boundaries.

About Daibi Medical Aesthetics
Location: Room 3301, No. 1158 Dongdaming Road, Hongkou District, Shanghai, China
CEO: Haibo Yu
Business: Provision of medical aesthetic services

About Nasukai
Location: 2F Maruito Ginza Building, 1-3-9 Ginza, Chuo-ku, Tokyo, Japan
Chairman: Keisuke Takeda
Business: Comprehensive medical services spanning specialized medicine, aesthetic medicine, insured medical care, and elective treatments

About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000^® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com/
For more insights and updates from SBC Holdings, follow us on LinkedIn

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Head of Public Relations: E-mail: pr@sbc.or.jp

ICR LLC (US Time)
Bill Zima / Managing Partner E-mail: bill.zima@icrinc.com

Strategic expansion positions Singapore as a strategic arm for healthcare logistics in the APAC region.

• DHL Group invests €10 million in a new pharmaceutical hub in Singapore to enhance international logistics and healthcare logistics infrastructure across the Asia-Pacific region.
• The expansion bolsters specialised services for shipping medicinal products, clinical trials, and medical devices via DHL Medical Express and a dedicated medical courier framework.
• This initiative contributes to a €500 million regional investment in health logistics by 2030, addressing the growing industry demand for reliable, temperature-controlled shipping solutions.

SINGAPORE, Feb. 2, 2026 /PRNewswire/ — DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of a €10 million Pharmaceutical Hub in Singapore. This investment bolsters regional Life Sciences and Healthcare (LSHC) infrastructure.

As a global leader in international logistics, DHL Express provides extensive network connectivity and operational expertise. In the life sciences and healthcare sector, the requirement for reliable and secure logistics continues to grow as global supply chains become increasingly complex.

Addressing the Growing Needs of a Modern Healthcare Supply Chain

The demand for specialised healthcare logistics is rising, driven by global health challenges, an ageing population, and the development of advanced therapies. In Singapore, the biomedical sector produces goods valued at nearly S$38 billion for global markets. The industry requires a health logistics infrastructure capable of accommodating the increasing volume and complexity of life-saving products distributed from regional hubs to the rest of the world.

In the modern healthcare supply chain, every step impacts patient well-being and critical research. Innovation in medical shipping is no longer optional; maintaining stringent temperature control for pharmaceuticals and navigating the regulatory demands of medical devices is critical.

By aligning with Singapore’s strategic vision, DHL provides the precision and reliability to support scientific progress and ensure that products are handled as required by the healthcare ecosystem.

DHL’s Reach in Life Sciences & Healthcare

DHL leverages an extensive global network spanning over 220 countries and territories to facilitate seamless international logistics. Through DHL Health Logistics and its services, the group utilises dedicated healthcare hubs and warehouses within a GDP-compliant infrastructure. This allows the group to support the global healthcare ecosystem with a combination of high-capacity transport and local handling.

With its Medical Express service (WMX), DHL Express ensures secure and compliant transport of sensitive shipment such as investigational drugs, medicinal products, and active pharmaceutical ingredients (API). The service offers a range of temperature-controlled solutions, from ambient to ultra-deep frozen (below -180°C). All solutions are fully compliant with UN 3373 and IATA Dangerous Goods standards.

Supported by a medical courier framework, DHL Health Logistics is optimised for urgent medical needs through priority delivery and time-definite collection schedule. All shipments are managed by certified specialists to ensure adherence to international healthcare standards and rigorous quality management certifications.

Setting Up the Next Vantage Point for Healthcare Logistics

DHL has strengthened its healthcare logistics capabilities in Singapore with the addition of the €10 million pharmaceutical hub, featuring specialised temperature zones and GMP-compliant infrastructure.

Located near Tuas Biomedical Park, this facility reinforces Singapore’s position as a strategic hub for Asia-Pacific, offering efficient connectivity to Changi Airport and Tuas Mega Port. These investments are part of a broader commitment to invest €500 million into regional health logistics by 2030, supporting resilience in global healthcare supply chains.

Leaving a Positive Impact on Life Sciences

The expansion of DHL Health Logistics is intended to support improved patient outcomes by facilitating timely delivery of critical medicines and medical devices. By strengthening its infrastructure, DHL provides the reliability required for shipping medicine and healthcare products through every stage of the supply chain:

• Pharmaceutical Logistics: DHL maintains GxP compliance and operational efficiency through strategic investments like the new Singapore Pharma Hub, which manages demand surges and large-scale vaccine distribution.
• Clinical Trial Logistics: The network provides specialised handling for Investigational Medicinal Products (IMP) and biological samples, supported by a global infrastructure of GMP-compliant depots and temperature-monitored shipping.
• Medical Device Logistics: “Device Final Mile” facilitates the delivery of medical devices and equipment directly to healthcare facilities. Aftermarket support maximises equipment uptime by supplying spare parts and repairs.
• Speciality Pharmaceutical Logistics: DHL ensures cold chain integrity across a spectrum of requirements, from ambient to cryogenic (-196°C) environments, utilising real-time monitoring to mitigate risks for sensitive shipments.
• Consumer Healthcare Logistics: To maintain product availability, DHL utilises automation and omnichannel fulfilment to bridge the gap between manufacturers and retail platforms.
• Aid and Relief Logistics: Leveraging a global network and dedicated Control Towers, DHL provides rapid response capabilities and procurement expertise for humanitarian missions and disaster relief.

This investment is a cornerstone of the DHL Group Strategy 2030, which focuses on expanding digitalisation, sustainability, and specialised infrastructure. By aligning these innovations with the evolving needs of the life sciences industry, DHL aims to be a trusted logistics partner for healthcare manufacturers and researchers worldwide. This vision also reaffirms DHL Express’s role as a pioneer in international logistics, transforming supply chains into reliable lifelines for patients worldwide.

Healthcare and life science partners are invited to collaborate with DHL to deliver reliable, innovative shipping solutions that ensure the safe, efficient delivery of medicinal products worldwide.

About DHL

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. Our DHL divisions offer a portfolio of logistics services ranging from national and international logistics, e-commerce shipping and fulfilment solutions, international express, road, air, and ocean transport, to industrial supply chain management. With approximately 400,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialised solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing & energy, auto-mobility and retail, DHL is positioned as “The logistics company for the world”.

DHL is part of DHL Group. The Group generated revenues of approximately 84.2 billion euros in 2024. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. DHL Group aims to achieve net-zero emissions logistics by 2050.

Five-country initiative addresses emerging compliance challenges as ASEAN tightens AI oversight

SINGAPORE, Feb. 2, 2026 /PRNewswire/ — Singapore has become the first country to release a governance framework for agentic AI. Minister for Digital Development and Information Josephine Teo announced the Model AI Governance Framework for Agentic AI at the World Economic Forum. The framework requires organizations to maintain human accountability for AI agents, implement technical controls, and ensure transparency.

Armor and Microsoft Security leaders at the Microsoft Digital Trust & Global Regulation Roadshow in Singapore, January 2026.

Armor Initiative Helps Enterprises Respond

Armor, a global leader in cloud-native managed detection and response and Microsoft Solutions Partner for Security, today announced an initiative spanning Singapore, Thailand, Malaysia, Indonesia, and the Philippines to help enterprises operationalize these new requirements.

Armor brings direct experience securing AI-driven enterprises. A healthcare technology company using GenAI tools to serve 800+ health systems achieved a 29x reduction in mean time to respond (MTTR) after partnering with Armor for 24/7 managed detection and response.

“Singapore’s Model AI Governance Framework for Agentic AI (MGF) recognizes what we’ve been telling clients: AI agents that can act autonomously need the same security rigor as any privileged user,” said Chris Drake, Founder and CEO of Armor. “You wouldn’t give an employee access to sensitive systems without visibility and controls. The same logic applies to AI.”

Armor Nexus: Security Operations Reimagined

Central to Armor’s approach is Nexus, its unified security operations platform built for teams who run their own SOCs. Unlike traditional SOCs that rely on manual processes and fragmented ticketing systems, Nexus was built by practitioners who defend organizations from the inside.

Nexus unifies operations and technology on a single platform because real incidents always involve both. The platform demystifies Microsoft security environments, giving organizations full visibility into their data. Customers can jump into the underlying intelligence and maintain the transparency that governance frameworks demand.

Organizations interested in participating can contact Armor’s team at armor.com.

About Armor

Armor is a global leader in cloud-native managed detection and response. Trusted by over 1,700 organizations across 40 countries, Armor delivers cybersecurity, compliance consulting, and 24/7 managed defense built for transparency, speed, and results. By combining human expertise with AI-driven precision, Armor safeguards critical environments to outpace evolving threats and build lasting resilience. For more information, visit armor.com or request a free Cyber Resilience Assessment.

Follow us on LinkedIn, X.

Media Contact:
Michele Glassman
Marketing Director, Armor
Email: michele.glassman@armor.com
Website: www.armor.com

Armor team members join Microsoft partners at Microsoft’s ASEAN offices as part of Armor’s five-country initiative to help enterprises operationalize Singapore’s new Model AI Governance Framework for Agentic AI.

KUALA LUMPUR, Malaysia, Feb. 2, 2026 /PRNewswire/ — Fraud in Southeast Asia has passed a tipping point, evolving from isolated scams to highly commercial operations run by organized syndicates operating with the scale and efficiency of modern, legitimate businesses. This warning was delivered by Niki Luhur, Founder and CEO of VIDA Group, at CISO Malaysia 2026, an event that brings together Chief Information Security Officers (CISOs) in Malaysia.

In his presentation, “From Fraudster to Syndicate: The Rise of Commercial Fraud in Southeast Asia,” Niki detailed how Artificial Intelligence (AI) is fundamentally reshaping the digital crime economy, automating and scaling fraud into a structured, industrialized threat. “Fraud today is no longer about individuals seeking quick profits; it has become a business,” said Niki Luhur. “When crime operates like an industry, security cannot rely on assumptions built for a different era.”

This message resonates with CISOs, as AI-powered threats like deepfake attacks and synthetic identity fraud erode traditional security models. And in line with Bank Negara Malaysia’s (BNM) decision to phase out SMS OTPs by June 2026, which underscores the inadequacy of legacy authentication and requires a fundamental redesign of defense strategies for banking leaders.

Niki emphasized layered and coordinated identity defense. Effective fraud prevention requires unifying identity verification, device integrity checks, liveness detection, and PKI authentication into a cohesive system that can withstand large-scale AI-based attacks. Device trust is now a critical frontline control. For more information, visit www.vida.id

About VIDA

VIDA is a leading company in Indonesia in the field of digital identity and fraud prevention, licensed Certification Authority (CA) registered under the Ministry of Communication and Digital Affairs of the Republic of Indonesia. Founded in 2018, VIDA provides digital identity services that integrate electronic certificates, digital signatures, identity verification, and transaction authentication, all adhering to world-class security standards, including Public Key Infrastructure (PKI) and biometric verification. VIDA verifies more than 2.5 million identities every day. For more information, visit www.vida.id

HONG KONG, Feb. 2, 2026 /PRNewswire/ — Wonder, a leading fintech and payments platform for merchants in Hong Kong and Asia Pacific, today announced it has raised a USD 12 million venture debt from HSBC Innovation Banking in Hong Kong. This multi-year debt capital commitment will support Wonder’s business growth across the Asia Pacific region, T+0 instant settlement, and product development.

The venture debt will provide Wonder with growth capital to scale its operations exponentially while continuing to innovate its full-stack omni-channel payments platform, serving a broad spectrum of industries including SMEs, insurers, telecommunication companies, multinational corporations, consumer retailers, transportation providers, and the public sector. 

“We are thrilled to announce our USD 12 million venture debt from HSBC. This funding will accelerate our expansion across the Asia Pacific, enabling us to bring enterprise-grade payment and fintech products to businesses of all sizes. As we embark on this exciting journey with HSBC’s financing support, we remain committed to innovation and empowering businesses to thrive in a digital economy, particularly with enabling SMEs to access T+0 instant settlements and improve cash flow efficiencies across the Asia Pacific Region. Together, we are well positioned to redefine the future of payments.” said Founder and CEO of Wonder, Jason Ngan, in a company statement.

Jonathan Yip, Head of Innovation Banking, Asia, HSBC said, “We are pleased to support pioneering fintech innovators like Wonder. By leveraging our specialist expertise and comprehensive financial solutions, HSBC Innovation Banking empowers Wonder to deliver an innovative platform for businesses of all sizes to streamline payment management. This transaction underscores our commitment to addressing the unique financial needs of high-growth, tech-led businesses in a holistic manner.”

This transaction marks a key milestone for Wonder in 2025. Over the past year, the Company has significantly expanded its gross payment volume, merchant base, industry verticals and product suites. Going forward, Wonder has set its sights on becoming a fintech and payments powerhouse in the Asia Pacific Region, covering key markets beyond Hong Kong SAR including Singapore, Australia, New Zealand, Malaysia, Japan, Taiwan region and Macau.

About Wonder

Wonder is a leading payments and FinTech platform for merchants in Hong Kong and Asia Pacific, enabling any merchant, from micro-businesses to multinational enterprises to pay and get paid effortlessly.

Wonder is Hong Kong’s first full-stack omni-channel payments platform, allowing merchants to digitally complete KYC onboarding in minutes, open an account, accept payments, pay digitally, and manage transactions all from one single platform. Key products include Wonder App, Wonder Terminal, Wonder Dashboard, Wonder Card and Wonder Taxi. Beyond the full-stack suite of payments and FinTech products, Wonder has also pioneered instant payments settlement (T+0) in Hong Kong and continues to expand access to digital financial services through innovation and strategic partnerships.

Headquartered in Hong Kong, Wonder has completed a Series A funding round led by Hong Kong Telecom (HKT) and a venture debt with HSBC Innovation Banking. Wonder has offices in Hong Kong SAR, Japan, Taiwan region, Singapore, Malaysia, Shenzhen, and Changsha.

Website: https://wonder.app

CONTACT:
Name: Wonder 
Email: inquiry@wonder.app

PHU QUOC, Vietnam, Feb. 2, 2026 /PRNewswire/ — As spring arrives along the tranquil shores of Kem Beach, Premier Residences Phu Quoc Emerald Bay welcomes Tet, the Vietnamese Lunar New Year, with celebrations flowing gently to the rhythm of the sea. This Tet, the resort invites guests to slow down, reconnect, and embrace the Year of the Horse — a peaceful beginning where joy lingers long after the holiday ends.

Set on Kem Beach, ranked among the world’s top 100 beaches, the resort blends contemporary design with Phu Quoc’s natural beauty. Mornings greet guests with sunlight dancing on emerald waters, while days unfold through moments shaped by tradition, togetherness, and island serenity. With 752 modern accommodations from studios and family apartments to penthouses and villas, each opens to calming sea views, creating a sense of home where guests can fully immerse themselves in the spirit of Tet by the waves.

A Tet Journey of Culture and Togetherness

This Lunar New Year, the resort presents a thoughtfully crafted Tet program, guiding guests through a seamless journey of cultural and joyful experiences. Children create colorful lanterns and God of Wealth charms, while Lion Dance performances bring vibrant energy to the resort. Guests can receive calligraphy blessings, participate in traditional folk games, and join the Foam Pool Party, where playful fun meets tropical sunshine. Every moment is designed to feel natural, unhurried, and personal, blending Vietnamese tradition with modern island celebration.

From Joy to Table: Tet Flavors by the Sea

Dining takes center stage as a language of reunion and warmth. The Traditional Tet Set Menu celebrates familiar Vietnamese flavors in an intimate seaside setting, while the Spring Reunion Buffet offers an abundant spread of local specialties and international favorites, perfect for family gatherings. Couples can enjoy romantic seaside dinners under candlelight, with gentle waves and glowing sunsets.

Herring Bar: Where Tet Meets the Sea Breeze

The resort’s Herring Bar, inspired by Phu Quoc’s fishing village heritage, adds a contemporary seaside touch. Guests can savor Vietnamese-inspired dishes, tropical cocktails, and ocean views, ideal for sunset gatherings or intimate Lunar New Year dinners.

Extending the Celebration at Tropica Fest

Beyond the resort, Tropica Fest at Sunset Town offers immersive experiences for culture, art, and entertainment lovers. With interactive installations, performances, and lively showcases, Tropica Fest adds color and energy, making Tet on Phu Quoc Island truly unforgettable.

A Lunar New Year That Lingers

Tet at Premier Residences Phu Quoc Emerald Bay is not defined by a single event but by the memories and emotions that unfold throughout the holiday. From family reunions and playful moments to romantic dinners and cultural exploration, every experience leaves a lasting impression.

This Lunar New Year, discover Tet by the waves, where nature’s beauty, Vietnamese tradition, and modern island living combine to create a celebration that stays in the heart long after the holiday ends.